The Assessment of Cardiac Masses by Cardiac CT and CMR Including Pre-op 3D Reconstruction and Planning

Liddy, Stephen; McQuade, Colin; Walsh, Kevin; Loo, B; Buckley, Orla

doi:10.1007/s11886-019-1196-7

Cited by 20 publications

(14 citation statements)

References 92 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…However, to better determine its delineation and relation to surrounding tissues, complementary imaging by cardiac MRI, during follow-up, maybe helpful to yield exact information regarding tumour localization, size, and its anatomic relation to the myocardium [37, 38]. At the same time, cardiac CT is superior to cardiac MRI spatial resolution and allows accurate assessment of the location of tumour mass, the degree of local invasion, and the encasement of the coronary arteries [38]. Echocardiography plays a role for CM detection, but it seems less reliable for first detection.…”

Section: Discussionmentioning

confidence: 99%

Cardiac Metastases in Patients with Neuroendocrine Tumours: Clinical Features, Therapy Outcomes, and Prognostic Implications

et al. 2020

View full text Add to dashboard Cite

Background: Cardiac metastases (CM) from neuroendocrine tumours (NET) are rare; however, with the introduction of new molecular imaging modalities, such as 68Ga-DOTATATE PET-CT for NET diagnosis and re-staging, they are now identified more frequently. This study presents a single-institution experience on the NET CM characteristics, management, and prognostic implications. Methods: Between January 1998 and January 2020, 25 NET patients with CM were treated in our unit. A retrospective review of electronic records was performed. Overall survival (OS) was assessed by the Kaplan-Meier method. Cox regression models were used to evaluate the association of various clinical variables with OS. Results: The median age in the NET CM cohort was 64 years, with small intestine being the most common primary (84%). Nearly half of the patients suffered either from shortness of breath (48%) or had palpitations (12%). Peptide receptor radionuclide therapy (PRRT) was applied in more than half of the patients (64%), who had an improved trend for a longer median OS compared to those patients who did not receive PRRT (76.0 vs. 14.0 months, p = 0.196). The multivariate analysis demonstrated that concomitant skeletal or pancreatic metastases, as well as N-terminal pro-B-type natriuretic peptide (NT pro-BNP) >2 × upper limit of normal (ULN), were independent poor prognosticators. Conclusions: Clinical features of NET CM ranged from asymptomatic patients to heart failure. Concomitant bone or pancreatic metastases and NT pro-BNP levels >2 ULN predicted shorter survival time. PRRT serves as a feasible therapy with promising survival benefits; however, more data are needed.

show abstract

Section: Discussionmentioning

confidence: 99%

Cardiac Metastases in Patients with Neuroendocrine Tumours: Clinical Features, Therapy Outcomes, and Prognostic Implications

et al. 2020

View full text Add to dashboard Cite

show abstract

“…3D-MRA is a new sequence that diagnoses cardiac tumors and can show vascular involvement. 3D reconstruction is a valuable auxiliary method for preoperative evaluation of cardiac masses, which can better describe the margin of the mass and its relationship with the surrounding structure (48). 3D printing is an emerging technology that makes the edges of cardiac tumors easier to visualize.…”

Section: New Techniques For Delineating Cardiac Tumorsmentioning

confidence: 99%

Cardiac magnetic resonance imaging of primary cardiac tumors

Chen

Liu

et al. 2020

Quant Imaging Med Surg

View full text Add to dashboard Cite

Cardiac magnetic resonance (CMR) offers superior advantages in cardiac imaging due to supplying a greater field of view, excellent soft-tissue imaging, and multiplanar imaging capabilities. CMR imaging can evaluate the characteristics of cardiac tumors by visualizing the relationship between the tumor and surrounding tissues, and plays a vital role in assisting the formulation of the surgical plan, the assessment of tumor progression, and the monitoring of postoperative tumor recurrence and metastasis. In this review, we present the clinical manifestations and imaging features of different cardiac tumors. The superior performance of CMR in preoperative diagnosis, surgical treatment, and postoperative follow-up of patients with heart tumors are also highlighted.

show abstract

“…Transesophageal echocardiography (TEE) may be required for more comprehensive assessment of the relationship of mass with surrounding structures and valve competence 9 . CT and RMI are generally reserved for patients in whom echocardiography is insufficient for diagnosis; moreover, they are particularly helpful to assess tumor extension and to facilitate preoperative planning 10 . Accordingly, TTE was our main diagnostic tool, aiding in determining tumor size and location.…”

Section: Discussionmentioning

confidence: 99%

“… 9 CT and RMI are generally reserved for patients in whom echocardiography is insufficient for diagnosis; moreover, they are particularly helpful to assess tumor extension and to facilitate preoperative planning. 10 Accordingly, TTE was our main diagnostic tool, aiding in determining tumor size and location. A small number of subjects received TC, MRI or TEE.…”

Section: Discussionmentioning

confidence: 99%

“…9 CT and RMI are generally reserved for patients in whom echocardiography is insufficient for diagnosis; moreover, they are particularly helpful to assess tumor extension and to facilitate preoperative planning. 10 In patients with benign cardiac neoplasms or in those with resectable primary malignant disease and no evidence of metastasis, surgery is generally indicated to improve prognosis. 11 For selected subjects, other approaches such as heart transplantation 12 or heart autotransplantation 13 should be considered.…”

mentioning

confidence: 99%

See 1 more Smart Citation

Surgical treatment of primary cardiac tumors in the contemporary era: A single‐centre analysis

Matteucci

Ferrarese

Mantovani

et al. 2021

Journal of Cardiac Surgery

View full text Add to dashboard Cite

Background: Primary cardiac tumors (PCT) are rare lesions but have the potential to cause significant morbidity if not timely treated. We reviewed our single-center experience in the surgical treatment of PCT with a focus on the long-term outcome.Methods: From 2001 to 2020, 57 consecutive patients underwent surgical resection of PCT at our Institution. Data including the demographic characteristics, tumor histology, surgical procedure, and postoperative outcomes were collected and analyzed.Results: Mean age at presentation was 63.6 ± 11.2 years, and 33 (57.9%) of the patients were female. A total of 55 (96.5%) subjects were diagnosed with benign cardiac tumor, while the remaining had malignant tumors. The most common histopathological type was myxoma. All patients survived to hospital discharge. Main postoperative complications were: acute kidney injury (n = 3), sepsis (n = 3), and stroke (n = 2). Mean follow-up time was 9 ± 5.9 years. Long-term mortality was 22.8% (13/57). No tumor recurrence was observed among survivors. There was a significant relationship between mortality and pathological characteristics of the tumor, and myxomas had higher survival rates. Conclusion:Surgical treatment of PCT is a safe and highly effective strategy associated with excellent short-term outcomes. Long-term survival remains poor for primary malignant tumors of the heart.

show abstract

The Assessment of Cardiac Masses by Cardiac CT and CMR Including Pre-op 3D Reconstruction and Planning

Cited by 20 publications

References 92 publications

Cardiac Metastases in Patients with Neuroendocrine Tumours: Clinical Features, Therapy Outcomes, and Prognostic Implications

Cardiac Metastases in Patients with Neuroendocrine Tumours: Clinical Features, Therapy Outcomes, and Prognostic Implications

Cardiac magnetic resonance imaging of primary cardiac tumors

Surgical treatment of primary cardiac tumors in the contemporary era: A single‐centre analysis

Contact Info

Product

Resources

About